Table 5 Functions/expression of genes co-expressed with eIF3m in triple negative breast cancer from BCIP database

QSER1

0.714601888

9.34E − 15

Over-expressed in ovarian cancer [17]

NM_024774

CSTF3

0.672936196

5.44E − 12

Over-expressed in colorectal cancer [18]

NM_001326

DPH4

0.653121381

6.09E − 11

Protein biosynthesis related with eEF2 [19]

NM_181706

APIP

0.652049629

6.09E − 11

an ERBB3-binding partner promoting tumorigenesis [20]

NM_015957

CAPRIN1

0.638113822

3.09E − 10

Carcinogenesis in breast cancer [21]

NM_005898

PDHX

0.635217128

3.80E − 10

Regulating glucose metabolism [22]

NM_003477

NAT10

0.603723528

1.29E − 08

Epithelial-mesenchymal transition [23]

NM_024662

C11orf46

0.594934276

2.94E − 08

Growth of the corpus callosum [24]

NM_152316

IMMP1L

0.591451963

3.81E − 08

Strongly implicated in obesity [25]

NM_144981

ELP4

0.556089434

1.06E − 06

Promoting the migration and invasion of hepatocellular carcinoma [26]

NM_019040

FBXO3

0.545140598

2.56E − 06

Regulating p53 transcriptional activity [27]

NM_012175

COMMD9

0.538715159

4.09E − 06

Promoting non-small cell lung cancer cancer progression via the activation of TFDP1/E2F1 transcriptional [28]

NM_014186

API5

0.523379598

1.34E − 05

Anti-apoptotic factor of breast cancer [29]

NM_006595

TRIM44

0.517213906

2.03E − 05

Promoting proliferation and invasion of thyroid cancer via Wnt/β-catenin [30]

NM_017583

TRAF6

0.513110012

2.62E − 05

Ubiquitinating DNA methyltransferase proteins [31]

NM_145803

CCDC34

0.501851465

5.76E − 05

Carcinogenesis in colorectal cancer [32]

NM_030771

C11orf74

0.48986957

0.000129328

Interacting with the IFT-A complex [33]

NM_138787

NUP160

0.484247975

0.000181588

Oncogene in angiosarcoma [34]

NM_015231

TCP11L1

0.477552672

0.000272389

Involved in heterozygous deletion and related with eIF3m [35]

NM_018393

CCNB3

0.476854234

0.000272389

Fused with BCOR and involved in cancer [36]

NM_033031